Clinical Trial Update: Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia. [Phase 2]

View source ↗

Summary

Phase 2a multiple ascending dose trial in hospitalized pneumonia patients is currently recruiting, sponsored by Vasomune Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Acute Respiratory Distress Syndrome
• Pneumonia
• Respiratory Distress Syndrome

Snippet

Sponsor: Vasomune Therapeutics, Inc. | Conditions: Acute Respiratory Distress Syndrome, Viral or Bacterial Infections | Phase 2 | Status: RECRUITING